CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 188 enrolled
Drug / intervention
Zofran +5 moredrug
Likely dose
Zofran 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02473042
NCT02473042N/ACompleted
CompareCT.gov

Intraoperative Electrical Stimulation of the Acupoint P6 to Prevent Post-Operative Nausea and Vomiting in Women Undergoing Breast Cancer Surgery

M.D. Anderson Cancer Center·interventional·Posted Jun 16, 2015·Updated Dec 5, 2025

In Brief

A clinical study evaluating Electrical Stimulation, Zofran, and 4 other interventions for Post-Operative Nausea and Vomiting and Breast Cancer. Completed, enrolled 188 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to learn if light electrical stimulation to the wrist area during surgery is feasible in women having breast surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-Operative Nausea and Vomiting, Breast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 16, 2015
Enrollment StartMar 1, 2016
Primary CompletionNov 26, 2024
TodayJul 2, 2026
Enrollment to primary: 8.7 yearsPosted 11.0 years ago

Interventions

Electrical Stimulationprocedure

Electrical stimulation to the wrist initiated at 1mHz, 1 pulse/second using two leads on a nerve stimulator. Stimulation continued throughout the breast surgery.

Zofrandrug

4 mg by vein for 1 dose.

Dexamethasonedrug

10 mg by vein for 1 dose.

Phenergandrug

6.25 mg by vein for 1 dose.

Pepciddrug

10 mg by vein for 1 dose.

Questionnairebehavioral

Questionnaire completed about 15 minutes after participant wakes up after surgery, then every 30 minutes until they leave the clinic. It should take about 2 - 3 minutes to complete the questionnaire.